In hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC), it is imperative to identify patients who respond poorly to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and to discover therapeutic targets to reverse this resistance. Non-luminal breast cancer subtype and high levels of C...
Bibliographic Details
| Authors: |
Guerrero-Zotano Á,
Belli S,
Zielinski C,
Gil-Gil M,
Fernandez-Serra A,
Ruiz-Borrego M,
Ciruelos Gil EM,
Pascual J,
Muñoz-Mateu M,
Bermejo B,
Margeli Vila M,
Antón A,
Murillo L,
Nissenbaum B,
Liu Y,
Herranz J,
Fernández-García D,
Caballero R,
López-Guerrero JA,
Bianco R,
Formisano L,
Turner N,
Martín M |
|---|
| Format: | article
|
|---|
| Status: | Published version |
|---|
| Publication Date: | 2023 |
|---|
| Country: | España |
|---|
| Institution: | Centro de Investigación Principe Felipe (CIPF) |
|---|
| Repository: | r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF) |
|---|
| OAI Identifier: | oai:cipf.fundanetsuite.com:p4090 |
|---|
| Online Access: | https://cipf.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4090
|
|---|
| Access Level: | Open access |
|---|
